We saw a clear volume spike in XHC.TO stock at market close on 12 Mar 2026, with the iShares Global Healthcare Index ETF (CAD-Hedged) trading at C$68.11 on the TSX. Volume jumped to 229,886 versus an average of 7,191, a relative volume of 31.97, while price fell 1.90% on the day. We view this as a liquidity-driven move that pushed technicals into oversold territory and created a short-term trading opportunity. Meyka AI’s real-time tools flagged the event for further analysis.
XHC.TO stock: Volume spike and trading context
Today’s spike shows 229,886 shares traded against a 7,191 average volume, a relative volume of 31.97.
The price traded between C$68.11 and C$68.90 before close, and the intraday move drove the one-day change to -1.90%, signalling heavier selling with high liquidity.
XHC.TO stock: Price action and technicals
The chart displays oversold signals with RSI 30.79 and CCI -128.96.
Momentum indicators show negative MACD (-0.67) and a lower Bollinger Band at C$68.63, putting immediate support near the 200-day average C$67.03 and resistance near the 50-day average C$71.46.
XHC.TO stock: Fundamentals and valuation
XHC.TO trades at C$68.11 with reported EPS C$2.73 and PE 24.96.
The fund carries a market cap of CAD 558,227,040.00 and a dividend per share of C$1.32, equal to a yield near 1.92%, reflecting income plus large-cap healthcare exposure.
XHC.TO stock: Meyka grade and forecast
Meyka AI rates XHC.TO with a score out of 100: 63.39 | Grade: B | Suggestion: HOLD.
This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, forecasts, and analyst data. Meyka AI’s forecast model projects monthly C$71.94 (+5.62%), quarterly C$80.19 (+17.74%), and yearly C$65.76 (-3.44%). Forecasts are model-based projections and not guarantees.
XHC.TO stock: Holdings, index exposure and sector
XHC.TO provides global large-cap healthcare exposure via S&P Global 1200 constituents, hedged to CAD monthly.
For a full holding list see the iShares holdings summary source. Context on ETF structure and similar funds is available source.
XHC.TO stock: Risks, opportunities and trade ideas
The main risk is sector weakness; the healthcare group shows negative short-term performance and elevated volatility.
The opportunity is a mean-reversion trade: oversold technicals plus high liquidity can offer a short-term bounce toward C$71.94, while failure below C$67.03 would favour a defensive stance.
Final Thoughts
Volume and technical data show XHC.TO stock moved on heavy trading at market close on 12 Mar 2026, with price at C$68.11 and 229,886 shares traded. The spike pushed indicators into oversold readings and highlighted a liquidity-driven swing. Meyka AI’s forecast model projects monthly C$71.94 (implied +5.62%) and a quarterly target of C$80.19 (implied +17.74%), while a one-year projection sits at C$65.76 (implied -3.44%). Use the 50-day average C$71.46 and the 200-day average C$67.03 as tactical levels. Our grade is B (HOLD) based on blended metrics and sector context. Forecasts are model-based projections and not guarantees. We emphasise position sizing and stop discipline when trading this ETF, and we note Meyka AI as an AI-powered market analysis platform that flagged this volume event for investors to watch.
FAQs
What caused the XHC.TO stock volume spike today?
The spike came from a surge to 229,886 shares versus a 7,191 average, indicating heavy liquidity and likely large orders or rebalancing. The event pushed price to C$68.11 and created oversold technicals for short-term traders.
What are short-term price targets for XHC.TO stock?
Meyka AI’s model sets a monthly target at C$71.94 (+5.62%) and a quarterly target at C$80.19 (+17.74%). Use the 50-day C$71.46 and 200-day C$67.03 as tactical levels.
How does XHC.TO stock pay income and what is the yield?
XHC.TO reports dividend per share C$1.32, which equates to a yield near 1.92% based on the current price. The ETF aims to provide marketlike exposure plus monthly CAD hedging.
What is Meyka AI’s view on XHC.TO stock grade?
Meyka AI rates XHC.TO with a score out of 100: 63.39 | Grade: B | Suggestion: HOLD. The grade blends benchmark comparison, sector data, metrics, forecasts, and consensus. It is informational and not investment advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)